Gill D G
Department of Paediatrics RCSI, Children's University Hospital, Temple Street, Dublin 1, Ireland.
Arch Dis Child. 2006 Mar;91(3):270-2. doi: 10.1136/adc.2005.081778.
This paper argues against the use of growth hormone (GH) for small normal children ("idiopathic" short stature) with the following considerations: ethical (philosophical) grounds, cost-economic implications, and the rationale for treating normal physiological variation with a potent pharmacological agent. The author would prefer to see health and economic resources being directed to correct nutritional and environmental deprivation among underprivileged groups in preference to providing GH injections for small normal children.
本文基于以下几点考虑，反对给正常身材矮小的儿童（“特发性”身材矮小）使用生长激素（GH）：伦理（哲学）依据、成本-经济影响，以及使用强效药物治疗正常生理变异的基本原理。作者更希望看到健康和经济资源用于纠正弱势群体中存在的营养和环境匮乏问题，而不是给正常身材矮小的儿童注射生长激素。
